These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 12405200)
1. Antiviral memory T cell responses: correlation with protective immunity and implication for vaccine development. Harari A; Ellefsen K; Champagne P; Nobile M; Pantaleo G Adv Exp Med Biol; 2002; 512():155-64. PubMed ID: 12405200 [No Abstract] [Full Text] [Related]
2. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Makedonas G; Betts MR Springer Semin Immunopathol; 2006 Nov; 28(3):209-19. PubMed ID: 16932955 [No Abstract] [Full Text] [Related]
3. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic vaccination against chronic viral infection: the importance of cooperation between CD4+ and CD8+ T cells. Zajac AJ; Murali-Krishna K; Blattman JN; Ahmed R Curr Opin Immunol; 1998 Aug; 10(4):444-9. PubMed ID: 9722921 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic analysis of human immunodeficiency virus (HIV) type 1 cell-mediated immune responses after treatment with an HIV-1 immunogen. Moss RB; Wallace MR; Giermakowska WK; Webb E; Savary J; Chamberlin-Brandt C; Theofan G; Musil R; Richieri SP; Jensen FC; Carlo DJ J Infect Dis; 1999 Sep; 180(3):641-8. PubMed ID: 10438350 [TBL] [Abstract][Full Text] [Related]
6. Exploiting 4-1BB costimulation for enhancing antiviral vaccination. Harrison JM; Bertram EM; Ramshaw IA Viral Immunol; 2006; 19(4):593-601. PubMed ID: 17201654 [TBL] [Abstract][Full Text] [Related]
7. Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses. Whitmire JK; Ahmed R Curr Opin Immunol; 2000 Aug; 12(4):448-55. PubMed ID: 10899032 [TBL] [Abstract][Full Text] [Related]
8. CD8 T cell dysfunction during chronic viral infection. Shin H; Wherry EJ Curr Opin Immunol; 2007 Aug; 19(4):408-15. PubMed ID: 17656078 [TBL] [Abstract][Full Text] [Related]
9. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses. Villacres MC; Zuo J; Bergmann CC Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979 [TBL] [Abstract][Full Text] [Related]
10. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine. Kawada M; Tsukamoto T; Yamamoto H; Takeda A; Igarashi H; Watkins DI; Matano T J Virol; 2007 May; 81(10):5202-11. PubMed ID: 17344296 [TBL] [Abstract][Full Text] [Related]
11. Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques. De Rose R; Chea S; Dale CJ; Reece J; Fernandez CS; Wilson KM; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Sullivan MT; Kent SJ Vaccine; 2005 Mar; 23(16):1949-56. PubMed ID: 15734067 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of CD8 T cells in response to acute and chronic viral infections: implications for HIV vaccine development. Curr Drug Targets Infect Disord; ; . PubMed ID: 15975018 [TBL] [Abstract][Full Text] [Related]